Home › Funds › Two Sigma Investments › RLMD
Two Sigma Investments position in RLMD
RELMADA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)214.91K sh
Reported value held$1.49M
Portfolio Weight0.00%
First reportedQ1 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 10.50K | $283.00K | New |
| Q2 2022 | 11.35K | $216.00K | Add |
| Q3 2022 | 51.89K | $1.92M | Add |
| Q4 2022 | 527.16K | $1.84M | Add |
| Q1 2023 | 404.27K | $913.66K | Reduce |
| Q2 2023 | 304.89K | $750.02K | Reduce |
| Q3 2023 | 197.20K | $591.59K | Reduce |
| Q4 2023 | 302.74K | $1.25M | Add |
| Q1 2024 | 227.04K | $1.06M | Reduce |
| Q2 2024 | 203.26K | $609.78K | Reduce |
| Q3 2024 | 191.31K | $619.86K | Reduce |
| Q4 2024 | 127.58K | $66.34K | Reduce |
| Q1 2025 | 170.54K | $46.05K | Add |
| Q1 2025 | 170.54K | $46.05K | Add |
| Q2 2025 | 95.42K | $57.28K | Reduce |
| Q2 2025 | 95.42K | $57.28K | Reduce |
| Q3 2025 | 173.61K | $348.96K | Add |
| Q4 2025 | 572.84K | $2.77M | Add |
| Q1 2026 | 408.10K | $2.84M | Reduce |
| Q2 2026 | 214.91K | $1.49M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RLMD
- Janus Henderson Group 11.06M sh · $76.89M · Q1 2026
- BlackRock Inc 7.43M sh · $51.39M · Q2 2026
- Geode Capital Management 2.49M sh · $17.25M · Q2 2026
- Millennium Management 2.36M sh · $16.34M · Q2 2026
- Marshall Wace 2.25M sh · $15.55M · Q2 2026
- Balyasny Asset Management 1.52M sh · $10.52M · Q2 2026
- Vanguard Group 1.20M sh · $5.81M · Q4 2025
- Bank of America Corp 812.06K sh · $5.62M · Q2 2026
- Northern Trust Corp 786.26K sh · $5.44M · Q2 2026
- Goldman Sachs Group 767.62K sh · $5.31M · Q2 2026
- Deutsche Bank AG 318.90K sh · $2.21M · Q2 2026
- BNY Mellon 295.62K sh · $2.05M · Q2 2026